FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:2459 June 9, 2005 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Edited by Gilles Lugassy, Anna Falanga, Ajay K. Kakkar, and Frederick R. Rickles. 230 pp. London, Martin Dunitz, 2004. $125. ISBN 1-84184-287-7.

The association between thrombosis and cancer represents a challenge to scientists and physicians of various disciplines. From a clinician's point of view, progress in this field during the past several years has been substantial. In a patient presenting with venous thrombosis who is otherwise healthy, for example, the likelihood that there is a hidden cancer is now well defined, and we have estimates of the risk of thrombosis among patients with cancer who are exposed to surgery, chemotherapy, or the insertion of a central venous catheter. With the development of new antithrombotic drugs, particularly the low-molecular-weight heparins, preventive and therapeutic . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.